Robert B M Landewé Selected Research

Robert B M Landewé Research Topics

Disease

28	Rheumatoid Arthritis 01/2021 - 02/2002
12	Ankylosing Spondylitis 06/2022 - 10/2005
10	Arthritis (Polyarthritis) 01/2022 - 01/2011
7	Axial Spondyloarthritis 01/2022 - 07/2015
7	Pain (Aches) 01/2019 - 01/2012
6	Necrosis 01/2021 - 10/2012
4	COVID-19 01/2022 - 10/2020
4	Cytokine Release Syndrome 04/2021 - 01/2020
3	Uveitis 06/2022 - 01/2011
3	Psoriatic Arthritis 01/2020 - 01/2012
3	Non-Radiographic Axial Spondyloarthritis 12/2019 - 07/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 01/2011
2	Neoplasms (Cancer) 06/2017 - 10/2012
2	Rheumatic Diseases (Rheumatism) 06/2017 - 03/2011
2	Infections 06/2017 - 10/2012
2	Gout 06/2015 - 09/2014
2	Inflammation (Inflammations) 07/2013 - 11/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022
1	Back Pain (Backache) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Fatigue 01/2018
1	Nausea 09/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2013
1	Overweight 10/2013
1	Spondylarthropathies 10/2013
1	Spondylarthritis (Spinal Arthritis) 01/2012
1	Liver Diseases (Liver Disease) 01/2012
1	Osteoarthritis 01/2012
1	Ulcerative Colitis 01/2011
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2011
1	Sarcoidosis (Schaumann Disease) 01/2011
1	Crohn Disease (Crohn's Disease) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2010

Drug/Important Bio-Agent (IBA)

9	GlucocorticoidsIBA 01/2022 - 09/2014
9	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2002
8	Antirheumatic Agents (DMARD)IBA 06/2022 - 04/2013
7	Biological ProductsIBA 01/2020 - 01/2011
6	tocilizumab (atlizumab)FDA Link 04/2021 - 01/2020
6	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 08/2012
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2016 - 01/2012
4	C-Reactive ProteinIBA 01/2022 - 03/2011
3	Adalimumab (Humira)FDA Link 01/2021 - 07/2013
3	Etanercept (Enbrel)FDA Link 01/2021 - 01/2018
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 02/2002
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2020
2	GLPG0634IBA 01/2021 - 01/2020
2	tofacitinibIBA 01/2021 - 01/2020
2	Certolizumab Pegol FDA Link 01/2020 - 01/2018
2	golimumab FDA Link 01/2020 - 10/2012
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2018 - 01/2017
2	amsonic acid (DAS)IBA 09/2017 - 02/2014
2	Naproxen (Naprosyn)FDA LinkGeneric 07/2015 - 01/2012
1	N-phthaloylglutamic acidIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Mono-SIBA 01/2021
1	baricitinibIBA 01/2020
1	upadacitinibIBA 01/2020
1	secukinumabIBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	InterleukinsIBA 01/2020
1	sarilumabIBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Janus KinasesIBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2020
1	Pharmaceutical PreparationsIBA 12/2019
1	Prostaglandins AIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 06/2015
1	Cyclooxygenase InhibitorsIBA 06/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2014
1	tenoxicamIBA 09/2014
1	Uric Acid (Urate)IBA 09/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014
1	AutoantibodiesIBA 10/2013
1	Tramadol (K315)FDA LinkGeneric 01/2012
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2012
1	Opioid Analgesics (Opioids)IBA 01/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2011
1	Immunomodulating AgentsIBA 01/2011
1	Adenosine (Adenocard)FDA LinkGeneric 11/2010
1	human CHI3L1 proteinIBA 09/2010
1	AutoantigensIBA 09/2010
1	GoldIBA 03/2010
1	GadoliniumIBA 10/2005
1	Prednisolone (Predate)FDA LinkGeneric 02/2002

Therapy/Procedure

16	Therapeutics 01/2021 - 02/2002
2	Injections 01/2020 - 02/2014
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Aftercare (After-Treatment) 08/2016
1	Intra-Articular Injections 02/2014
1	Pain Management 01/2012
1	Intranasal Administration 09/2010
1	Immunotherapy 09/2010